Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerGiannis Mountzios, Petros Christopoulos, Sofia Agelaki et al.|ESMO Open|2021Cited by 93
Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology GroupHelena Linardou, George Fountzilas, Nikolaos Spanakis et al.|Cancers|2021Cited by 41
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Dimitrios Bafaloukos, Sofia Lampaki et al.|Cancer Immunology Immunotherapy|2021Cited by 39
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, G. Koumakis, Georgia-Angeliki Koliou et al.|ESMO Open|2020Cited by 38